Preclinical study shows oral PL7737 agonist outperforms tirzepatide alone in rodent models, supporting Palatin’s plans for ...

Sun Pharmaceutical Industries, announced its release of Leqselvi in the U.S. earlier this week. Leqselvi™ is currently ...

A proactive strategy that promotes U.S. pharmaceutical manufacturing is a crucial pillar within a resilient and diversified ...

Alliance Pharmaceuticals, a U.S. based pharmaceutical solutions provider, announced its new partnership with TrueMed, an AI-based anti-counterfeit detection company. The partnership was formed with ...

The OUTREACH Study – Demonstrating that CAR-T therapies can be effectively administered in community cancer settings: In the ...

Corina Dutcus, SVP, oncology global clinical development lead, Eisai, highlights how consistent survival data from the LEAP-002 study reaffirms lenvatinib’s value in first-line treatment of ...

A Harvard Business School Healthcare Alumni Association Q&A with Dr. Henry A. McKinnell, former Chairman and CEO of Pfizer.

Marcel Botha discusses whether AI can truly be used to replace laid off human workers at FDA.

Approval of Kerendia was based on results from the Phase III FINEARTS-HF trial, which demonstrated statistically significant ...

The majority of respondents not already enrolled in the program have concerns that the program won’t survive until the point ...

Willis Chandler is the new president and CEO of Knipper Health. The news came alongside the announcement that Frazier ...

The specific parameters defined in your label, including patient population, line of therapy, and outcomes measured, will now ...